Gritstone Bio Number of Employees 2017-2024 | GRTSQ
Gritstone Bio number of employees from 2017 to 2024. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis
| Gritstone Bio Annual Employee Count |
| 2023 |
231 |
| 2022 |
233 |
| 2021 |
193 |
| 2020 |
169 |
| 2019 |
174 |
| 2018 |
113 |
| 2017 |
100 |
| 2016 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.000B |
$0.016B |
|
Gritstone Oncology is developing tumor-specific cancer immunotherapies to fight multiple cancer types. The company has built its tumor-specific immunotherapy approach on two key pillars - first, a proprietary machine learning-based platform, Gritstone EDGE(TM), which provides a powerful ability to predict from a routine tumor biopsy the tumor-specific neoantigens, or TSNA, that are presented on a patient?s tumor cells; and second, the ability to develop and manufacture potent immunotherapies utilizing patients? TSNA to drive the patient?s immune system to attack and destroy tumors.
|
